Top Markets
Coin of the day
FUREN Group Pharmaceutical Co., Ltd. FUREN Group Pharmaceutical Co., Ltd.

FUREN Group Pharmaceutical Co., Ltd.

600781
Rank in Stocks #23723
FUREN Group Pharmaceutical Co., Ltd. primarily focuses on the development and... FUREN Group Pharmaceutical Co., Ltd. primarily focuses on the development and distribution of medicinal products across China, with key operations located in Henan Province and Shanghai. The company offers a wide array of traditional Chinese medicines, available in various formats such as capsules, tablets, granular formulations, gels, injectable solutions, and oral liquids. Among its notable therapeutic solutions are granular preparations designed for cardiac ailments, alongside encapsulated treatments for managing diabetes and high cholesterol. Furthermore, the company diversifies its business by engaging in warehousing logistics and commercial trading activities. Established in 1996, the firm maintains its headquarters in Shanghai, China.
Share Price
$0.11158369
Last synced: 2023-06-19
Market Cap
$69.98M
Change (1 day)
1.95%
Change (1 year)
0.00%
Country
CN
Trade FUREN Group Pharmaceutical Co., Ltd. (600781)

Category

P/B ratio for FUREN Group Pharmaceutical Co., Ltd. (600781)
P/B ratio as of 2026 TTM: 0
According to FUREN Group Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for FUREN Group Pharmaceutical Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors